Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Comment on: 'evaluation of chemoresponse assays as predictive markers'.

Tian C, Gabrin MJ, Brower SL, Sargent DJ.

Br J Cancer. 2015 Jun 9;112(12):1977-8. doi: 10.1038/bjc.2015.156. Epub 2015 May 19. No abstract available.

2.

Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective study.

Tian C, Sargent DJ, Krivak TC, Powell MA, Gabrin MJ, Brower SL, Coleman RL.

Br J Cancer. 2014 Aug 26;111(5):843-50. doi: 10.1038/bjc.2014.375. Epub 2014 Jul 8.

3.

A systematic evaluation of multi-gene predictors for the pathological response of breast cancer patients to chemotherapy.

Shen K, Song N, Kim Y, Tian C, Rice SD, Gabrin MJ, Symmans WF, Pusztai L, Lee JK.

PLoS One. 2012;7(11):e49529. doi: 10.1371/journal.pone.0049529. Epub 2012 Nov 21.

4.

Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trial.

Shen K, Qi Y, Song N, Tian C, Rice SD, Gabrin MJ, Brower SL, Symmans WF, O'Shaughnessy JA, Holmes FA, Asmar L, Pusztai L.

BMC Med Genomics. 2012 Nov 16;5:51. doi: 10.1186/1755-8794-5-51.

5.

Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines.

Shen K, Rice SD, Gingrich DA, Wang D, Mi Z, Tian C, Ding Z, Brower SL, Ervin PR Jr, Gabrin MJ, Tseng G, Song N.

PLoS One. 2012;7(7):e40900. doi: 10.1371/journal.pone.0040900. Epub 2012 Jul 16.

Supplemental Content

Loading ...
Write to the Help Desk